- $191.14m
- $121.54m
- $59.63m
- 46
- 28
- 73
- 47
Annual income statement for 908 Devices, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 26.9 | 42.2 | 46.9 | 50.2 | 59.6 |
Cost of Revenue | |||||
Gross Profit | 14.9 | 23.2 | 26 | 25.3 | 29.9 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 32.7 | 64.3 | 82.2 | 93 | 136 |
Operating Profit | -5.82 | -22.1 | -35.4 | -42.8 | -76.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -12.8 | -22.2 | -33.6 | -36.6 | -72.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -12.8 | -22.2 | -33.6 | -36.4 | -72.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -12.8 | -22.2 | -33.6 | -36.4 | -72.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.9 | -22.2 | -33.6 | -36.4 | -72.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.473 | -0.793 | -1.07 | -1.13 | -1.33 |
Dividends per Share |